Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-003559
Filing Date
2008-03-28
Accepted
2008-03-27 17:45:07
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2184166z10-k.htm 10-K 1045872
2 EXHIBIT 3.1 a2184166zex-3_1.htm EX-3.1 22891
3 EXHIBIT 10.3 a2184166zex-10_3.htm EX-10.3 119465
4 EXHIBIT 10.26 a2184166zex-10_26.htm EX-10.26 51143
5 EXHIBIT 21 a2184166zex-21.htm EX-21 2041
6 EXHIBIT 23 a2184166zex-23.htm EX-23 3005
7 EXHIBIT 31.1 a2184166zex-31_1.htm EX-31.1 7332
8 EXHIBIT 31.2 a2184166zex-31_2.htm EX-31.2 7481
9 EXHIBIT 32.1 a2184166zex-32_1.htm EX-32.1 3666
10 EXHIBIT 32.2 a2184166zex-32_2.htm EX-32.2 3688
  Complete submission text file 0001047469-08-003559.txt   1268112
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 08716128
SIC: 2834 Pharmaceutical Preparations